Chronic Metabolic Diseases: Shifting from Symptom Control to Functional Healing
In Berlin, where medical innovation meets public health policy, a quiet revolution is reshaping how chronic metabolic diseases are treated. For decades, conditions like type 2 diabetes, obesity-related hypertension, and non-alcoholic fatty liver disease (NAFLD) were managed through lifelong symptom control—medications to lower blood sugar, insulin to compensate for resistance, or statins to mitigate cardiovascular … Read more